Yellow fever: epidemiology and prevention

Area of Science:

• * Virology and Immunology
• * Vaccine Safety and Epidemiology

Background:

• * Yellow fever remains endemic in Africa and South America, necessitating vaccination.
• * Despite vaccine availability, severe neurologic and multiorgan adverse events have been reported post-vaccination.
• * These rare events necessitate a deeper understanding of vaccine risks and benefits.

Purpose of the Study:

• * To establish criteria for the appropriate use of the yellow fever vaccine.
• * To detail the range of adverse events associated with yellow fever vaccination.
• * To investigate host factors influencing adverse event risk and explore potential treatments.

Main Methods:

• * Literature review of reported yellow fever vaccine-associated adverse events.
• * Analysis of epidemiological data on vaccine safety.
• * Investigational studies on host susceptibility and therapeutic interventions.

Main Results:

• * Severe neurologic and multiorgan diseases are rare but recognized adverse events following yellow fever vaccination.
• * Certain host factors are suspected to increase the risk of these adverse events.
• * Ongoing research aims to elucidate these risk factors and develop treatment strategies.

Conclusions:

• * Judicious use of yellow fever vaccine is critical, balancing efficacy against potential risks.
• * Further research is essential to understand and mitigate rare but severe vaccine-associated adverse events.
• * Identifying at-risk populations and developing targeted treatments are key priorities.